Jessa Boubker

Jessa Boubker

Foley & Lardner LLP

Contact
View Bio
RSS

Latest Posts › Obesity

Share:

GLP-1 Receptor Agonists: Clinical Trial Considerations

The U.S. Food & Drug Administration (FDA) has approved certain GLP-1 drugs for commercialization and use, including liraglutide (Victoza®), semaglutide (Ozempic®, Wegovy®), and tirzepatide (Mounjaro®, Zepbound®). Although...more

7/23/2025  /  Clinical Trials , FDA Approval , Food and Drug Administration (FDA) , Healthcare , Obesity , Off-Label Use , Pharmaceutical Industry , Prescription Drugs , Regulatory Requirements
1 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide